Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alphawave IP surges as Qualcomm says it's considering takeover offer

(Sharecast News) - Alphawave IP surged on Tuesday after Qualcomm confirmed that it is considering making an offer for the company. In a very brief statement, the US chipmaker said there can no certainty that any firm offer will be made, nor as to the terms on which any firm offer might be made.

Under takeover rules, Qualcomm has until the end of play on 29 April to either announce a firm intention to make an offer or walk away.

"A further announcement will be made if and when appropriate," it said.

The news came just hours after Reuters reported that SoftBank-owned chip tech provider Arm Holdings recently sought to acquire Alphawave.

The shares closed up 14.8% at 107.38p, having hit as high as 143.00p earlier in the session.

Danni Hewson, head of financial analysis at AJ Bell, said: "Perhaps the most thought-provoking news of the day proves that the world isn't standing still whilst it figures out what Mr Trump has in store.

"Shares in UK listed Alphawave rocketed on confirmation that US chipmaker Qualcomm is considering a bid. Qualcomm has been doubling down on AI innovation and bringing the UK company on board would enhance its own capabilities.

"Whilst the AI story has lost a little of its stardust over the past few months, there is still a hugely attractive business case for investing in the kind of tech that can improve productivity and drive further innovation.

"There's no guarantee that the talking stage will go any further, but if it does then it could set up one of the biggest deals on UK markets so far this year."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.